GENEVA, Aug. 31 -- ODYSSEY THERAPEUTICS, INC. filed a patent application (US2026/015997) for “INHIBITORS OF RIPK2 AND USES THEREOF”. With publication no. WO/2026/178334, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07D 471/04
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....